Eurofins Scientific

Pennsylvania
Pharmaceuticals Biotechnology and Life Sciences

Corporate Bias Rating

Expand Summary

Risk Level:

Rating - Caution
Medium Risk

Summary:

By complying with Human Rights Campaign’s controversial demands, Eurofins increases the risk of dividing employees, alienating customers and harming shareholders. The company provides a benefits package for employees which covers transgender medical procedures for covered employees and dependents, including children. It also uses sex and gender ideology criteria in employee recruitment, vendor selection, marketing, and philanthropic support. Eurofins forces employees to undergo multiple ideological trainings and uses its reputation, corporate funds, and political influence to support controversial sex and gender ideologies, organizations, and legislation. Eurofins supports ESG within its business practices and has donated to the Lancaster LGBTQ+ Coalition and the Lancaster's Pride Fest. For these reasons, Eurofins receives a Medium Risk rating.

View Full Report
Generate Reports
Clear
Toast